Eli Lilly has reported that its interleukin-13 (IL-13) inhibitor Ebglyss (lebrikizumab-lbkz) showed sustained skin clearance ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a ...

The Institute for Clinical and Economic Review (ICER) has updated its assessment of the value of Novo Nordisk’s (NOV: N) ...

LLY's rapid dealmaking spree across biotech and gene therapy aims to expand its pipeline beyond cardiometabolic drugs and ...

Eli Lilly & Co. has joined forces with artificial intelligence chipmaker Nvidia Corp. to develop what the companies describe as the most powerful supercomputer operated by a pharmaceutical firm. The ...

The firm will ‘begin recruitment for Hyderabad location, with openings across roles such as engineers, chemists, analytical scientists, quality control and assurance professionals and management posit ...